GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arovella Therapeutics Ltd (ASX:ALA) » Definitions » Float Percentage Of Total Shares Outstanding

Arovella Therapeutics (ASX:ALA) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 11, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Arovella Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Arovella Therapeutics's float shares is 0.00 Mil. Arovella Therapeutics's total shares outstanding is 1,050.16 Mil. Arovella Therapeutics's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Arovella Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Arovella Therapeutics's Institutional Ownership is 0.32%.

Arovella Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Arovella Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/1,050.16
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arovella Therapeutics (ASX:ALA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arovella Therapeutics Ltd (ASX:ALA) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
ASX:RCE ASX:PIQ ASX:PAA ASX:PAR ASX:OCC ASX:DXB ASX:ACW ASX:AGN ASX:SPL ASX:ADO OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
E4NA:Germany
Address
62 Lygon Street, Level 3, Carlton, WA, AUS, 3053
Website
https://www.arovella.com
Arovella Therapeutics Ltd is a biotechnology company focused on developing therapies to treat human diseases. Its two focus areas are oncology and conditions that impact the central nervous system. The company's principal activity is the pharmaceutical development of its invariant Natural Killer T (iNKT) cell platform for the treatment of cancer.

Arovella Therapeutics (ASX:ALA) Headlines

No Headlines